These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1685605)

  • 1. [Aerobic training guidelines in beta blocker therapy. An update].
    Samitz G
    Wien Med Wochenschr; 1991; 141(18-19):399-405. PubMed ID: 1685605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta-blockers on exercise physiology: implications for exercise training.
    Gordon NF; Duncan JJ
    Med Sci Sports Exerc; 1991 Jun; 23(6):668-76. PubMed ID: 1679517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of ratings of perceived exertion for exercise prescription in patients receiving beta-blocker therapy.
    Eston R; Connolly D
    Sports Med; 1996 Mar; 21(3):176-90. PubMed ID: 8776008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical performance and muscle metabolism during beta-adrenergic blockade in man.
    Kaiser P
    Acta Physiol Scand Suppl; 1984; 536():1-53. PubMed ID: 6151777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of exercise training heart rate in patients on beta-blockers after myocardial infarction.
    Tabet JY; Meurin P; Ben Driss A; Thabut G; Weber H; Renaud N; Odjinkem N; Solal AC
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):538-43. PubMed ID: 16874142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
    Gauri AJ; Raxwal VK; Roux L; Fearon WF; Froelicher VF
    Am Heart J; 2001 Jul; 142(1):136-41. PubMed ID: 11431669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers in hypertensive and coronary heart disease.
    Goldstein S
    Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance training for chronic heart failure patients on beta blocker medications.
    Levinger I; Bronks R; Cody DV; Linton I; Davie A
    Int J Cardiol; 2005 Jul; 102(3):493-9. PubMed ID: 16004896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers, dyslipidemia, and coronary artery disease. A reassessment.
    Burris JF
    Arch Intern Med; 1993 Sep; 153(18):2085-92. PubMed ID: 8104394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers do not impair the cardiovascular benefits of endurance training in hypertensives.
    Westhoff TH; Franke N; Schmidt S; Vallbracht-Israng K; Zidek W; Dimeo F; van der Giet M
    J Hum Hypertens; 2007 Jun; 21(6):486-93. PubMed ID: 17330056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerobic exercise prescription in patients with chronic heart failure: a review in the beta-blocker era.
    Carvalho VO
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):570-4. PubMed ID: 22828773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension.
    Predel HG; Mainka W; Schillings W; Knigge H; Montiel J; Fallois J; Agrawal R; Schramm T; Graf C; Giannetti BM; Bjarnason-Wehrens B; Prinz U; Rost RE
    J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts.
    Frishman WH
    Circulation; 1983 Jun; 67(6 Pt 2):I11-8. PubMed ID: 6133640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic and metabolic responses to prolonged exercise after chronic beta 1-adrenoceptor blockade in hypertensive man.
    Frisk-Holmberg M; Juhlin-Dannfelt A; Aström H
    Clin Physiol; 1985 Jun; 5(3):231-42. PubMed ID: 2860992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of exercise training level in coronary artery disease patients on beta blockers.
    Tabet JY; Meurin P; Teboul F; Tartiere JM; Weber H; Renaud N; Massabie R; Driss AB
    Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):67-72. PubMed ID: 18277188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.